Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
Articles > Article · 2019
Authors: Kazuhiko Nakagawa, Edward B Garon, Takashi Seto, Makoto Nishio, Santiago Ponce Aix, Luis PazAres, ChaoHua Chiu, Keunchil Park, Silvia Novello, Ernest Nadal, Fumio Imamura, Kiyotaka Yoh, JinYuan Shih, Kwok Hung Au, Denis MoroSibilot, Sotaro Enatsu, Annamaria Zimmermann, Bente FrimodtMoller, Carla VisserenGrul, MARTİN RECKENFELDERBBAUMER, Tuncay GÖKSEL, ÖZGÜR ÖZYILKAN
LANCET ONCOLOGY, Journal Indexed in SCI Expanded, International, 2019, vol 20, pp 1655-1669